Skip to main content
Premium Trial:

Request an Annual Quote

It'll Protect You, But Maybe Not All the Time

Over at Genomeboy, Misha Angrist has a post about the GINA legislation -- his feelings are made clear in the title: "GINA: a harsh, exceptionalist mistress?" Misha's been reading details of the law, which was intended to prevent discrimination based on genetic information, and concludes, "The more I read this statute, the less I like it." His post includes excerpts from GINA showing possibilities for fairly large loopholes in the law.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.